Gadoteridol

Gadoteridol
Clinical data
Other names	(10-(2-(hydroxy-κO)propyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3−)-κN1,κN4,κN7,κN10,κO1,κO4,κO7)-gadolinium
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Routes of; administration	IV
ATC code	V08CA04 (WHO) ;
Legal status
Legal status	US: ℞-only ;
Identifiers
	IUPAC name gadolinium(+3) cation; 2-[4-(2-hydroxypropyl)-7,10-bis(2-oxido-2-oxoethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;
CAS Number	120066-54-8 ;
PubChem CID	60714;
DrugBank	DB00597 ;
ChemSpider	54719 ;
UNII	0199MV609F;
KEGG	D01137 ;
ChEBI	CHEBI:31643 ;
ChEMBL	ChEMBL1200593 ;
CompTox Dashboard (EPA)	DTXSID2048662 ;
Chemical and physical data
Formula	C17H29GdN4O7
Molar mass	558.69 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES [Gd+3].[O-]C(=O)CN1CCN(CCN(CCN(CC(O)C)CC1)CC([O-])=O)CC([O-])=O;
	InChI InChI=1S/C17H32N4O7.Gd/c1-14(22)10-18-2-4-19(11-15(23)24)6-8-21(13-17(27)28)9-7-20(5-3-18)12-16(25)26;/h14,22H,2-13H2,1H3,(H,23,24)(H,25,26)(H,27,28);/q;+3/p-3 ; Key:DPNNNPAKRZOSMO-UHFFFAOYSA-K ;
	(what is this?) (verify)

Gadoteridol (INN) is a gadolinium-based MRI contrast agent, used particularly in the imaging of the central nervous system. It is sold under the brand name ProHance.

References

Bracco Diagnostic Inc. (May 2007). "Gadoteridol (ProHance) prescribing information (revised May 2007)". DailyMed. U.S. National Library of Medicine. Retrieved 2008-07-13.

This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.